These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 421039)

  • 1. Pathogenesis of amyloid disease.
    Br Med J; 1979 Jan; 1(6158):216. PubMed ID: 421039
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral and cellular aspects of amyloid disease: present status.
    Scheinberg MA; Wohlgethan JR; Cathcart ES
    Prog Allergy; 1980; 27():250-76. PubMed ID: 6766217
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical evidence for the biphasic development of experimental amyloidosis.
    Sipe JD; McAdam KP; Uchino F
    Lab Invest; 1978 Jan; 38(1):110-4. PubMed ID: 621923
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloidosis in (CBA/J X A/J)F2 mice: correlation of amyloid resistance and low mitogenic response to concanavalin A.
    Wohlgethan JR; Cathcart ES
    J Immunol; 1981 Sep; 127(3):1003-7. PubMed ID: 7264297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology and pathogenesis of experimental amyloidosis.
    Ranlov P
    Dan Med Bull; 1968 Dec; 15(10):289-96. PubMed ID: 4912501
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceleration of murine amyloidosis by implantation of amyloid-containing grafts.
    Ono S; Cui D; Kunitsugu I; Hoshii Y; Kawano H; Takahashi M; Gondo T; Ishihara T
    Amyloid; 2005 Dec; 12(4):226-32. PubMed ID: 16399647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR; Cathcart ES
    Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of inflammatory cells in the pathogenesis of amyloidosis.
    Kisilevsky R; Axelrad M; Corbett W; Brunet S; Scott F
    Lab Invest; 1977 Dec; 37(6):544-53. PubMed ID: 599900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental murine amyloidosis: a model system for studying amyloid formation.
    Baumal R; Wilson B; Pass E
    Can Med Assoc J; 1975 Sep; 113(6):512-6. PubMed ID: 1080430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of heterospecific antiserum against lymph node cells on the development of experimental amyloidosis in mice.
    Ranlov P
    Acta Pathol Microbiol Scand; 1967; 69(4):534-42. PubMed ID: 6031367
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the pathogenesis of a familial form of renal amyloidosis.
    Mornaghi R; Rubinstein P; Franklin EC
    Trans Assoc Am Physicians; 1981; 94():211-6. PubMed ID: 7344220
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic amyloidosis/beta-fibrillosis].
    Schmiegelow K
    Ugeskr Laeger; 1983 Jul; 145(28):2147-51. PubMed ID: 6612850
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloidogenesis-theories and facts.
    Pruzanski W
    J Rheumatol; 1977; 4(3):219-22. PubMed ID: 926099
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
    Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
    Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloid neuropathy].
    Ikegawa S
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1371-3. PubMed ID: 1966018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current aspects of the etiopathogenesis and therapy of amyloid disease: future trends].
    Scheinberg MA
    Rev Paul Med; 1980; 96(5-6):108-11. PubMed ID: 6784226
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
    Bellotti V; Merlini G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amyloidosis: an immunoproliferative disease].
    Lovisetto P; Ricci C; Marchi L; Biarese V
    Recenti Prog Med; 1973 Sep; 55(3):229-48. PubMed ID: 4203558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.